Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
Stock Information for Vistagen Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.